A detailed history of Rhumbline Advisers transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 81,900 shares of PRME stock, worth $198,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81,900
Previous 81,900 -0.0%
Holding current value
$198,198
Previous $162,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 08, 2025

BUY
$1.72 - $3.35 $17,103 - $33,312
9,944 Added 13.82%
81,900 $162,000
Q4 2024

May 29, 2025

SELL
$2.64 - $4.46 $26,252 - $44,350
-9,944 Reduced 12.14%
71,956 $210,000
Q4 2024

Jan 30, 2025

BUY
$2.64 - $4.46 $5,039 - $8,514
1,909 Added 2.73%
71,956 $210,000
Q3 2024

Nov 12, 2024

SELL
$3.41 - $6.7 $204 - $402
-60 Reduced 0.09%
70,047 $271,000
Q2 2024

Aug 01, 2024

BUY
$4.3 - $8.03 $75,658 - $141,287
17,595 Added 33.51%
70,107 $360,000
Q1 2024

May 09, 2024

BUY
$6.35 - $9.39 $10,502 - $15,531
1,654 Added 3.25%
52,512 $367,000
Q4 2023

Feb 08, 2024

SELL
$5.59 - $9.55 $564 - $964
-101 Reduced 0.2%
50,858 $450,000
Q3 2023

Nov 09, 2023

BUY
$9.5 - $15.07 $37,012 - $58,712
3,896 Added 8.28%
50,959 $486,000
Q2 2023

Aug 08, 2023

BUY
$11.41 - $17.05 $536,988 - $802,424
47,063 New
47,063 $689,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $232M
More about PRME
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.